3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
2
Drug-Related Side Effects and Adverse Reactions
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphoid
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Interventions
Methylprednisolone
3
Social Determinants of Health
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegaspargase
1
Vincristine
1
Temozolomide
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pharmaceutical Services
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Irinotecan
1
Infliximab
1
Hydrocortisone
1
Fecal Microbiota Transplantation
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Cytarabine
1
Cyclophosphamide
1
Cefixime
1
CTLA-4 Antigen
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Social Determinants of Health
×
1 year
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT05078190
2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled